OSM and breast carcinoma: Here, we discovered that the cytokine oncostatin M (OSM) acts as a central regulator of the crosstalk between immune cells, CAFs, and cancer cells, and that these immune-stromal–cancer cell interactions favor breast cancer progression and metastasis.